FAM227A and prostate carcinoma: Because the higher expression levels of FAM227A in prostate cancer tissues than in normal tissues in TCGA and the GSE200879 dataset was observed (Fig. 3C and 3D), we then conducted stratification analyses based on clinical characteristics in the TCGA database to verify the association of FAM227A with the progression of prostate cancer.